Evidence map›Paper›PMID 32734692›Full record

ArticleChemMedChem2021

MS Binding Assays for Glycine Transporter 2 (GlyT2) Employing Org25543 as Reporter Ligand.

Thomas M Ackermann, Lars Allmendinger, Georg Höfner, Klaus T Wanner

Abstract read
In one paragraph

Article in ChemMedChem, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Opiranserin (VVZ-149): what's new in analgesics.The Korean journal of pain · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Thomas M AckermannDepartment of Pharmacy, Center for Drug Research, Ludwig-Maximilians-Universität Munich, Butenandtstraße 7, 81377, Munich, Germany.
Lars AllmendingerDepartment of Pharmacy, Center for Drug Research, Ludwig-Maximilians-Universität Munich, Butenandtstraße 7, 81377, Munich, Germany.
Georg HöfnerDepartment of Pharmacy, Center for Drug Research, Ludwig-Maximilians-Universität Munich, Butenandtstraße 7, 81377, Munich, Germany.
Klaus T WannerDepartment of Pharmacy, Center for Drug Research, Ludwig-Maximilians-Universität Munich, Butenandtstraße 7, 81377, Munich, Germany.ORCID 0000-0003-4399-1425

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study describes the first binding assay for glycine transporter 2 (GlyT2) following the concept of MS Binding Assays. The selective GlyT2 inhibitor Org25543 was employed as a reporter ligand and it was quantified with a highly sensitive and rapid LC-ESI-MS/MS method. Binding of Org25543 at GlyT2 was characterized in kinetic and saturation experiments with an off-rate of 7.07×10

Indexed as

Tandem Mass SpectrometryBenzamidesChromatography, High Pressure LiquidDeuteriumGlycine Plasma Membrane Transport ProteinsHEK293 CellsHumansKineticsLigandsProtein Binding4-benzyloxy-3,5-dimethoxy-N-(1-(dimethylaminocyclopently)methyl)benzamideBenzamidesDeuteriumGlycine Plasma Membrane Transport ProteinsLigandsSLC6A5 protein, humanbinding assayglycine transporter 2liquid chromatographymass spectrometryneurotransmitter

Identifiers

PMID32734692
PMCPMC7821181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.